PCAT-1 is the first lincRNA identified that participates in DSB repair in prostate cancer [118], and extends the “BRCA-ness” paradigm to include lncRNAs, in addition to mutations in DNA repair genes. This evidence concerns the gene PCAT1 and prostate cancer.